Williams‑Sonoma insider files Form 144/A to sell 90,000 shares via Merrill Lynch
Rhea-AI Filing Summary
Williams‑Sonoma, Inc. insider notice of proposed sale (Form 144/A). The filing shows 90,000 shares of common stock listed with Merrill Lynch (555 California St, San Francisco) to be sold approximately on 09/15/2025 with an aggregate market value of $18,011,359.40. The securities were acquired as 135,000 RSUs on 04/16/2024 and paid in cash. The filer previously sold 30,000 shares on 07/15/2025 for gross proceeds of $5,044,278.19. The filing includes the standard insider representation that the seller is not aware of undisclosed material adverse information.
Positive
- Disclosure compliance: The filing includes broker details, acquisition date, amount, and recent sales, meeting Rule 144/A reporting elements.
- Sale sourced from RSUs: Securities were acquired as 135,000 RSUs on 04/16/2024, indicating the shares are vested equity previously granted.
Negative
- Insider sale planned: The filer intends to sell 90,000 shares on 09/15/2025, which may be interpreted by some investors as insider liquidity.
- Recent prior sale: The filer sold 30,000 shares on 07/15/2025 for $5,044,278.19, showing ongoing insider dispositions in the period.
Insights
TL;DR Insider filing discloses planned sale of vested RSUs; size is small relative to total shares outstanding.
The Form 144/A documents an intended sale of 90,000 common shares via Merrill Lynch and shows the issuer's outstanding share count as 121,790,333, implying the planned sale represents a very small fraction of outstanding stock. The securities originated from RSUs granted on 04/16/2024 and the filer also reported a recent sale of 30,000 shares on 07/15/2025. From an equity‑analysis perspective this appears to be routine liquidity activity by an insider rather than a company operational disclosure.
TL;DR Filing appears to satisfy Rule 144 disclosure requirements and includes required seller attestation.
The Form 144/A contains required broker identification, amount to be sold, acquisition details (RSU grant date and amount), and recent insider sales, and it is marked as a LIVE submission. The notice includes the statutory attestation regarding absence of undisclosed material adverse information, aligning with standard compliance practices for insider dispositions under Rule 144.